George Horng, M.D. , Scientist; Staff Physician at CPMC, Division Chief of Pulmonary and Critical Care Medicine

California Pacific CURRENTS: The online journal of CPMC Research Institute

Pioneering new advances in pulmonary and critical care medicine
  • Endobronchial ultrasound

    An ultrasound view of endobronchial ultrasound (EBUS) guided fine needle aspiration of the right paratracheal lymph node.

  • Right upper lobe pulmonary nodule

    Axial PET/CT image of right upper lobe pulmonary nodule showing increased metabolic activity in the pulmonary nodule and right paratracheal lymph nodes. Increased metabolic activity is suggestive of malignancy but may, be due to infection or inflammation.

     

+

Research Overview

  • Dr. Horng is board-certified in critical care medicine, internal medicine, and pulmonary disease, and he specializes in the evaluation and diagnosis of pulmonary nodules and masses.
  • He has co-authored clinical research papers on predicting tumor response to therapy after oncogene inactivation; progressive dyspnea after CABG; tumorigenesis in lung adenocarcinomas and lymphomas; and multidrug resistance in cancer cells.
  • Past honors for Dr. Horng include a Teacher of the Year Award for CPMC’s Internal Medicine Residency Program and an American Thoracic Society Fellows Career Development Award. He was Resident of the Year at the University of California, Los Angeles/Greater Los Angeles VA Medical Center Internal Medicine Training Program.

Training

Dr. Horng received his M.D. at the University of California, San Diego School of Medicine. He completed residency training in internal medicine at the University of California, Los Angeles VA Medical Center, followed by a fellowship in pulmonary and critical care medicine at Stanford University in Palo Alto, California.


 

Publication Search

Publications

Carlsson A, Nair VS, Luttgen MS, Keu KV, Horng G, Vasanawala M, Kolatkar A, Jamali M, Iagaru AH, Kuschner W, Loo BW Jr, Shrager JB, Bethel K, Hoh CK, Bazhenova L, Nieva J, Kuhn P, Gambhir SS, Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer. J Thorac Oncol

Tran PT, Bendapudi PK, Lin HJ, Choi P, Koh S, Chen J, Horng G, Hughes NP, Schwartz LH, Miller VA, Kawashima T, Kitamura T, Paik D, Felsher DW, Survival and death signals can predict tumor response to therapy after oncogene inactivation. Sci Transl Med

Levashova Z, Backer MV, Horng G, Felsher D, Backer JM, Blankenberg FG, SPECT and PET imaging of EGF receptors with site-specifically labeled EGF and dimeric EGF. Bioconjug Chem

Horng GS, Ashley E, Balsam L, Reitz B, Zamanian RT, Progressive Dyspnea After CABG: Complication of Retained Epicardial Pacing Wires. Ann Thorac Surg

Tran PT, Fan AC, Bendapudi PK, Koh S, Komatsubara K, Chen J, Horng G, Bellovin DI, Giuriato S, Wang CS, Whitsett JA, Felsher DW, Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas. PLoS One

George Horng, M.D. , Scientist; Staff Physician at CPMC, Division Chief of Pulmonary and Critical Care Medicine
Primary Research Interests
  • Pulmonary and critical care medicine
  • Pulmonary nodules and masses
  • Tumor response to therapy after oncogene inactivation
  • Tumorigenesis in lung adenocarcinomas and lymphomas
  • Multidrug resistance in cancer cells